Navigation Links
Phone-based Therapy Eases Depression Long Term

SEATTLE— When people receive brief telephone-based psychotherapy soon after starting on antidepressant medication, //strong positive effects may continue// 18 months after their first session. So concludes a Group Health study in the April Journal of Consulting and Clinical Psychology.

This paper describes one more year of follow-up since a 2004 Journal of the American Medical Association (JAMA) report on the same random sample of Group Health patients.

“With close to 400 patients, this is the largest study yet of psychotherapy delivered over the telephone,” said Evette J. Ludman, PhD, senior research associate, Group Health Center for Health Studies, the paper’s lead author. “It’s also the first to study the effectiveness of combining phone-based therapy with antidepressant drug treatment as provided in everyday medical practice.”

Long-term positive effects of initially adding phone-based therapy included improvements in patients’ symptoms of depression and satisfaction with their care, said Ludman. At 18 months, 77 percent of those who got phone-based therapy (but only 63 percent of those receiving regular care) reported their depression was “much” or “very much” improved. Those who received phone-based therapy were slightly better at taking their antidepressant medication as recommended, but that did not account for most of their improvement. And effects were stronger for patients with moderate to severe depression than for those with mild depression.

“We were surprised at how well the positive effects were maintained over time,” said Ludman. “As with weight control, maintaining improvement is the hardest part of treating depression.”

As is usual in clinical practice, the patients’ primary care doctors diagnosed their depression and prescribed their antidepressants. Half of the patients also received eight sessions of telephone psychotherapy during the first six months, then two to four “booster” session
'"/>




Page: 1 2 3

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
(Date:12/2/2008)...le Reminder, the nation,s leading,comprehensive p...in industry,technology today at Javits Center in ...ring and distributing video testimonials can be us...to popular platforms such as YouTube, Google,Vide...s with an effective,business strategy for increas...
(Date:12/2/2008)...of enterprise software and online services veteran...ubscribers of Yugma,s instant web conferencing sol...(PRWEB) December 2, 2008 -- Yugma , the leading w...nd collaborate instantly using the Internet, annou...ecutive Officer. , , ,Vas has more than 20 years o...
(Date:12/2/2008)...-Specific Gamma Imaging (BSGI) has,been proven to...iagnosis of,invasive lobular carcinoma (ILC), a d...ecular breast imaging technique that can see lesio...y early stage cancers. When compared to,mammograp...), BSGI has the,greatest sensitivity for detectin...
(Date:12/2/2008)...ocedure, study says , , TUESDAY, Dec. 2 ...rm of epilepsy who don,t respond to drugs would ga...oved quality of life at that, if they had a certai...f a new study that relied on computer modeling to ...e region for people with temporal lobe epilepsy. ,...
Breaking Medicine News(10 mins):Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2Health News:Surgery a Boon for Most Common Form of Epilepsy 2Health News:Surgery a Boon for Most Common Form of Epilepsy 3
...vide crucial drugs to patients who suffer from mod...ch have been unveiled. // There were protests from... Institute for Health and Clinical Excellence (NIC...onger cost effective, and the NHS will not provide...
...n drug plan came in to effect on Jan 1st, but the ...a, have trouble dealing with the issue//. The pla...mbers of Medicare came to know about it when they ...scription drug plan. The plan was very difficult t...
...ich is used for treating lung and sinus infections...to a report. //Medical practitioners belonging to ...three cases of liver failure in patients to whom t...ng to the Annals of Internal Medicine. All three...
...y source has revealed that the bird flu has claime...e H5N1 virus in the country to 14.//The World Heal...ld girl and her four-year-old brother died last we...er of the children who died, along with a sister o...
Other Medicine News:Health News:Bush’s new prescription drug plan, a complex puzzle for the citizen 2
(Date:11/30/2008)...ire-USNewswire/ -- Older adults who exercise regul...ter number of small blood vessels in the brain, ac...meeting of the Radiological Society of North Ameri... University of North Carolina ( UNC) - Chapel Hi...adults who exercise to brain scans of those who do...
(Date:11/27/2008)...e lymphoblastic leukemia relapse cases arise from ... , MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNew...ch Hospital have identified distinctive genetic ch...ymphoblastic leukemia (ALL) that cause relapse. Th... for ALL relapse in children and, ultimately, in a...
(Date:11/25/2008)...ry , , Audio and Web Video Resources to acc... News Blog. Please see the bottom of this release .... 25 A Mayo Clinic stud...they,re having a stroke -- and as a result -- dela... The findings appear in the current issue of Emerg...
(Date:11/25/2008)... Poniard,Pharmaceutical...pany focused on,innovative oncology therapies, an... alternatives for its preclinical research program...urces on the clinical development of picoplatin,...tial commercialization of,picoplatin in the treat...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3SXC Health Solutions announces third quarter financial results 28943 1SXC Health Solutions announces third quarter financial results 28943 2SXC Health Solutions announces third quarter financial results 28943 3SXC Health Solutions announces third quarter financial results 28943 4SXC Health Solutions announces third quarter financial results 28943 5SXC Health Solutions announces third quarter financial results 28943 6SXC Health Solutions announces third quarter financial results 28943 7SXC Health Solutions announces third quarter financial results 28943 8SXC Health Solutions announces third quarter financial results 28943 9SXC Health Solutions announces third quarter financial results 28943 10SXC Health Solutions announces third quarter financial results 28943 11SXC Health Solutions announces third quarter financial results 28943 12SXC Health Solutions announces third quarter financial results 28943 13SXC Health Solutions announces third quarter financial results 28943 14SXC Health Solutions announces third quarter financial results 28943 15SXC Health Solutions announces third quarter financial results 28943 16SXC Health Solutions announces third quarter financial results 28943 17SXC Health Solutions announces third quarter financial results 28943 18SXC Health Solutions announces third quarter financial results 28943 19SXC Health Solutions announces third quarter financial results 28943 20PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 1PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 2PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 3PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 4PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 5Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 1Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 2Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 3Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 4LocumTenens com Finds Psychiatrists are Neutral on Universal Healthcare 28934 1LocumTenens com Finds Psychiatrists are Neutral on Universal Healthcare 28934 2LocumTenens com Finds Psychiatrists are Neutral on Universal Healthcare 28934 3
...roof of concept in topical models of,infection , R... Ltd.,(SWX: ARPN) today announced positive results...against a large panel of,clinical isolates, includ...In addition, topical applications of AR-2474 were ...illin resistant,Staphylococcus aureus (MRSA) in pr...
... 2007--The World Health Organization,has released ...in,Pakistan. , So is this another instance where, ...ical industry is denying important vaccines to,poo... London’s Guardian,newspaper, “parents...o allow health workers to administer polio vaccina...
Other Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Why Is Polio Spreading in Pakistan? 2
...rad™ thermal cycler expands the envelope of ...™ cyler. It has four times the capacity with...igh throughput for laboratories that run massive q...nostic labs. Four blocks, each available with the...
...x3005P instrument and custom filter wheels with yo... set includes: FAM/SYBR Green I (492nm-516nm), HEX...), Cy5 (635nm-665nm) and Cy3 (545-568). The system...ware, Beacon Designer oligo software, User's Manua...
Ideal for day-to-day temperature cycling ,Unmatched well-to-well uniformity of 0.1C ,30% reduction in cycling time over Peltier or coolant-based cyclers ,4 programmable blocks eliminate tempera
...s: Mx3005P instrument and custom filter wheels wit...lter set includes: FAM/SYBR Green I (492nm-516nm),...10nm), Cy5 (635nm-665nm) and Cy3 (545-568). Also i...are, Beacon Designer oligo software, User's Manual...
Medicine Products: